What is Global Intravitreal (IVT) Injectables Market?
The Global Intravitreal (IVT) Injectables Market is a specialized sector of the pharmaceutical industry that focuses on the production and distribution of injectable drugs used for intravitreal administration. Intravitreal refers to the process of injecting medication directly into the eye, specifically into the vitreous, which is the clear, gel-like substance that fills the space between the lens and the retina. This method of administration is commonly used for treating a variety of eye conditions, including macular degeneration, diabetic retinopathy, and retinal vein occlusion. The market for these injectables is global, meaning it spans across all continents and involves numerous pharmaceutical companies, healthcare providers, and patients. The value of this market is determined by the demand for these injectables, which is influenced by factors such as the prevalence of eye conditions, advancements in pharmaceutical research and development, and the accessibility and affordability of healthcare services.
Anti-VEGF, Corticosteroids, Antibiotics, Antivirals, Antifungals in the Global Intravitreal (IVT) Injectables Market:
The Global Intravitreal (IVT) Injectables Market is segmented based on the type of drug used, which includes Anti-VEGF, Corticosteroids, Antibiotics, Antivirals, and Antifungals. Anti-VEGF drugs are the most prevalent, accounting for over 85% of the market. These drugs work by inhibiting the growth of abnormal blood vessels in the eye, which is a common cause of vision loss in diseases like macular degeneration. Corticosteroids are used to reduce inflammation in the eye, while antibiotics, antivirals, and antifungals are used to treat various types of eye infections. Each of these drug types has its own market within the larger IVT Injectables Market, with different manufacturers, distribution channels, and patient demographics.
Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies, Others in the Global Intravitreal (IVT) Injectables Market:
The usage of Global Intravitreal (IVT) Injectables spans across various areas including Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies, and others. Hospital Pharmacies are the primary users of these injectables, as most intravitreal injections are administered in a hospital setting by a trained healthcare professional. Retail Pharmacies and Drug Stores also make up a significant portion of the market, as they provide patients with the necessary medications for post-injection care. Mail Order Pharmacies offer a convenient option for patients who may not have easy access to a physical pharmacy, while other outlets include online pharmacies and direct purchases from the manufacturer. Each of these areas contributes to the overall value and growth of the Global Intravitreal (IVT) Injectables Market.
Global Intravitreal (IVT) Injectables Market Outlook:
The Global Intravitreal (IVT) Injectables Market has shown significant growth over the years. In 2023, the market was valued at US$ 14530 million and is projected to reach US$ 22480 million by 2030, growing at a CAGR of 6.3% during the forecast period from 2024 to 2030. This growth can be attributed to the increasing prevalence of eye conditions that require intravitreal injections, advancements in drug development, and the expansion of healthcare services worldwide. The market is dominated by the top five manufacturers, who collectively hold a share of over 70%. North America is the largest market, accounting for over 50% of the global share, followed by Europe and Asia-Pacific, both of which hold a share of over 40%.
| Report Metric | Details |
| Report Name | Intravitreal (IVT) Injectables Market |
| Accounted market size in 2023 | US$ 14530 million |
| Forecasted market size in 2030 | US$ 22480 million |
| CAGR | 6.3% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Regeneron Pharmaceuticals, Bausch & Lomb, Novartis, Allergan, Alimera Sciences, ThromboGenics, Bristol-Myers Squibb |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
